Schedule of Effective Income Tax Rate Reconciliation (Details) - Sonnet BioTherapeutics Holdings, Inc. [Member] |
12 Months Ended | |
|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| U.S. federal statutory rate | (21.00%) | (21.00%) |
| State taxes, net of federal benefit | (5.80%) | (7.10%) |
| Change in valuation allowance | (8.30%) | 30.80% |
| Research and development credit | (4.60%) | (5.10%) |
| Permanent differences | 2.70% | (1.60%) |
| Foreign tax rate differential | 0.10% | 0.30% |
| State net operating losses | 3.70% | |
| Sale of state net operating losses and research and development credits | 51.50% | |
| Other | (14.60%) | |
| Effective income tax rate | ||
| X | ||||||||||
- Definition Effective income tax rate reconciliation permanent differences. No definition available.
|
| X | ||||||||||
- Definition Effective income tax rate reconciliation sale of state net operating losses and research and development credits. No definition available.
|
| X | ||||||||||
- Definition Effective income tax rate reconciliation state net operating losses. No definition available.
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|